1. Home
  2. CYTK vs CCK Comparison

CYTK vs CCK Comparison

Compare CYTK & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$80.44

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Logo Crown Holdings Inc.

CCK

Crown Holdings Inc.

HOLD

Current Price

$117.02

Market Cap

12.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
CCK
Founded
1997
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Containers/Packaging
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
12.2B
IPO Year
2004
2003

Fundamental Metrics

Financial Performance
Metric
CYTK
CCK
Price
$80.44
$117.02
Analyst Decision
Strong Buy
Buy
Analyst Count
19
16
Target Price
$89.26
$121.19
AVG Volume (30 Days)
2.3M
1.0M
Earning Date
05-05-2026
04-27-2026
Dividend Yield
N/A
1.41%
EPS Growth
N/A
79.72
EPS
N/A
1.56
Revenue
$13,368,000.00
$11,665,000,000.00
Revenue This Year
$7.37
$5.17
Revenue Next Year
$310.19
$2.38
P/E Ratio
N/A
$74.76
Revenue Growth
N/A
N/A
52 Week Low
$32.89
$89.21
52 Week High
$88.31
$116.69

Technical Indicators

Market Signals
Indicator
CYTK
CCK
Relative Strength Index (RSI) 49.47 72.50
Support Level $59.07 $98.32
Resistance Level $88.31 N/A
Average True Range (ATR) 2.98 2.89
MACD -0.86 0.24
Stochastic Oscillator 21.81 86.43

Price Performance

Historical Comparison
CYTK
CCK

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About CCK Crown Holdings Inc.

Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

Share on Social Networks: